6-甲氧基-1,2,3,4-四氢-9-H-吡啶[3,4-b]吲哚结构式
|
常用名 | 6-甲氧基-1,2,3,4-四氢-9-H-吡啶[3,4-b]吲哚 | 英文名 | 6-METHOXY-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE |
|---|---|---|---|---|
| CAS号 | 20315-68-8 | 分子量 | 202.25200 | |
| 密度 | 1.198 g/cm3 | 沸点 | 388.6ºC at 760 mmHg | |
| 分子式 | C12H14N2O | 熔点 | 219-222ºC(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 188.8ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
| 中文名 | 2,3,4,9-四氢-6-甲氧基-1H-吡咯[3,4-B]吲哚 |
|---|---|
| 英文名 | 6-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole |
| 中文别名 | 2,3,4,9-四氢-6-甲氧基-1H-吡啶并[3,4-B]吲哚 | 6-甲氧基-1,2,3,4-四氢-9H-吡啶并[3,4-B]吲哚 | 6-甲氧基-1,2,3,4-四氢-β-咔啉 |
| 英文别名 | 更多 |
| 密度 | 1.198 g/cm3 |
|---|---|
| 沸点 | 388.6ºC at 760 mmHg |
| 熔点 | 219-222ºC(lit.) |
| 分子式 | C12H14N2O |
| 分子量 | 202.25200 |
| 闪点 | 188.8ºC |
| 精确质量 | 202.11100 |
| PSA | 37.05000 |
| LogP | 2.15100 |
| 外观性状 | 黄褐色光敏固体 |
| 蒸汽压 | 3.03E-06mmHg at 25°C |
| 折射率 | 1.639 |
| 储存条件 | 密闭,阴凉,干燥处 |
| 稳定性 | 按规定使用和贮存的不会分解,避氧化物、光 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):1.5 2.氢键供体数量:2 3.氢键受体数量:2 4.可旋转化学键数量:1 5.互变异构体数量:无 6.拓扑分子极性表面积37 7.重原子数量:15 8.表面电荷:0 9.复杂度:234 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1. 性状:白色固体 2. 密度(g/mL25 ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):219-222 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,0.87hPa):未确定 7. 折射率:未确定 8. 闪点(ºF):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(mmHg,20 ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(正辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xi: Irritant; |
| 风险声明 (欧洲) | R36/37/38 |
| 安全声明 (欧洲) | 26-36 |
| 危险品运输编码 | NONH for all modes of transport |
| RTECS号 | UV0725000 |
|
~94%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Pellegrini; Strassler; Weber; Borschberg Tetrahedron Asymmetry, 1994 , vol. 5, # 10 p. 1979 - 1992 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 22 p. 5840 - 5843 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 24 p. 4421 - 4425 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 22 p. 5840 - 5843 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Journal of the Chemical Society, , p. 4589,4591 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Pharmaceutical Chemistry Journal, , vol. 17, # 8 p. 559 - 563 Khimiko-Farmatsevticheskii Zhurnal, , vol. 17, # 8 p. 936 - 940 |
|
~%
6-甲氧基-1,2,3,4-四... 20315-68-8 |
| 文献:Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, , vol. 39, # 10 p. 849 - 860 |
|
Melatonin and structurally-related compounds protect synaptosomal membranes from free radical damage.
Int. J. Mol. Sci. 11 , 312-28, (2010) Since biological membranes are composed of lipids and proteins we tested the in vitro antioxidant properties of several indoleamines from the tryptophan metabolic pathway in the pineal gland against o... |
|
|
In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by melatonin and pinoline.
J. Pineal Res. 49(1) , 78-85, (2010) The protective in vivo effects of melatonin or pinoline on carbon tetrachloride (CCl(4))-induced oxidative damage were investigated in liver of rats and compared to rats injected only with CCl(4) (5 m... |
|
|
Pinoline may be used as a probe for CYP2D6 activity.
Drug Metab. Dispos. 37(3) , 443-6, (2009) Pinoline, 6-methoxy-1,2,3,4-tetrahydro-beta-carboline, is a serotonin analog that selectively inhibits the activity of monoamine oxidase-A and shows antidepressant activity. Our previous study using a... |
| MFCD00012071 |
| 6-methoxytryptoline |
| 6-Methoxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole |
| 6-MeOthbc |